Collagenase-Functionalized Liposomes Overcome Stromal Barriers in Pancreatic Cancer
ACS Nano · 03.03.2026 · 20 (8) · 7184-7204
DOI: 10.1021/acsnano.5c20618 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, online erschienen am 18.02.2026. Verfasst von Jee-Eun Hwang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Se…. Hauptthemen laut MEDLINE: Collagenases, Liposomes, Pancreatic Neoplasms, Deoxycytidine. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Korea Health Industry Development Institute, National Research Foundation of Korea, Korea Evaluation Institute of Industrial Technology.
Abstract (Originalsprache)
High Resolution Image Download MS PowerPoint Slide Pancreatic ductal adenocarcinoma (PDAC) features a dense desmoplastic stroma dominated by type I collagen, which forms a physical barrier that limits vascular perfusion and drug penetration, resulting in poor therapeutic outcomes. Here, we report gemcitabine-loaded collagenase-conjugated liposomes (GLCLs) that enzymatically remodel the collagen-rich extracellular matrix (ECM) while delivering a cytotoxic payload. GLCL retained enzymatic activity and stability, exhibited prolonged circulation, and achieved superior tumor accumulation with deeper and more homogeneous intratumoral gemcitabine penetration than nonfunctionalized liposomes. In PDAC-bearing mice, GLCL showed a 6-fold higher tumor growth inhibition (69.8%) than gemcitabine-loaded liposomes without collagenase (GLL; 10.9%) at the same dose. Importantly, this work provides the first molecular-level validation of nanocarrier-mediated drug penetration in PDAC, achieved through a multiscale approach combining in vivo imaging, ex vivo fluorescence, and quantitative desorption electrospray ionization mass spectrometry imaging (DESI-MSI). GLCL enzymatically overcomes PDAC’s fibrotic collagen barrier, offering a clinically translatable strategy for deep intratumoral drug delivery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul 08826, Republic of Korea.
- Cancer Research Institute, Seoul National University, Seoul 03080, Republic of Korea.
- Research Institute for Convergence Science, Seoul National University, Seoul 08826, Republic of Korea.
- Department of Applied Bioengineering, Graduate School of Convergence Science and Technology, Seoul National University, Seoul 08826, Republic of Korea.
- School of Transdisciplinary Innovations, Seoul National University, Seoul 08826, Republic of Korea.
ORCID-Profile: Haena Park, Jae Kyoo Lee, Hyung-Jun Im
Förderung
- Korea Health Industry Development Institute
- National Research Foundation of Korea
- Korea Evaluation Institute of Industrial Technology
Zitieren
APA
Hwang, J. E., Jeon, M., Yim, H., Park, J., Kim, H. S., Lee, S., Park, H., Lee, J. K., & Im, H. J. (2026). Collagenase-Functionalized Liposomes Overcome Stromal Barriers in Pancreatic Cancer. ACS Nano, 20(8), 7184-7204. https://doi.org/10.1021/acsnano.5c20618
Vancouver
Hwang JE, Jeon M, Yim H, Park J, Kim HS, Lee S, et al. Collagenase-Functionalized Liposomes Overcome Stromal Barriers in Pancreatic Cancer. ACS Nano. 2026;20(8):7184-7204. doi:10.1021/acsnano.5c20618
BibTeX
@article{Hwang2026,
author = {Hwang, Jee-Eun and Jeon, Miyeon and Yim, Hyunjoon and Park, Jiwoo and Kim, Hong-Sik and Lee, Subin and Park, Haena and Lee, Jae Kyoo and Im, Hyung-Jun},
title = {Collagenase-Functionalized Liposomes Overcome Stromal Barriers in Pancreatic Cancer},
journal = {ACS Nano},
year = {2026},
volume = {20},
number = {8},
pages = {7184--7204},
doi = {10.1021/acsnano.5c20618}
}
EUVIMED